Third phase of Sputnik V trials starts in Russia

By:

Fecha de publicación:

5 September 2020

Imagen principal:

Moscow, Sep 5 (Prensa Latina) The third phase of the trials for the Sputnik V Covid-19 vaccine will begin in September in Russia, according to an article issued in a specialized magazine.

The scientific Lansat journal published all the details and comments about Sputnik V, including its advantage over other similar vaccine candidates because of applying a double vector of human adenovirus and its injection in two doses that rises its effect.

Kirill Dmitriev, head of the Russian Fund for Direct Investments explained so; such entity works on the production of the Sputnik V vaccine, the first registered in the world against Covid-19, along with the National Center for Epidemiology and Microbiology N.F. Gamalei.

According to Dmitriev, the vaccine produces twice the antibodies created by recoveries from Covid-19, unlike other vaccine candidates with chimpanzee adenovirus, where the level of antibodies matches that of cured patients.

The expert pointed out that one of Lansat's comments highlights the almost non-existence of severe side effects of Sputnik 5, just a slight fatigue that passes in a short time.

The Moscow Mayor Sergei Sabianin affirmed to Russia's President Vladimir Putin on a report that the city has already been vaccinated with Sputnik-V, as part of the preparations to the city march to celebrate its 873 anniversary in Covid-19 times.